In our study, the CTLA-4 +49 GG and the haplotype ACGG/ACGG reduced the overall survival in ALL after allo-HSCT from the related HLA-haplotype-mismatched donor (67.7 vs. 90.3 %, P = 0.015). The gene discussed is CTLA4; the disease is acute lymphoblastic leukemia.